STOCKS TELEGRAPH

Author: Asim Kamal

  • Here is why Co-Diagnostics Inc. (CODX) stock had a good Thursday?

    Here is why Co-Diagnostics Inc. (CODX) stock had a good Thursday?

    Co-Diagnostics Inc. (CODX) shares jumped 13.06% in after-hours on Thursday, November 11, 2021, and closed the daily trading at $9.78. Even in the regular trading session, CODX’s stock gained 0.12%. CODX shares have fallen 34.96% over the last 12 months, and they have moved up 1.53% in the past week. Over the past three months, the stock has lost 18.40%, while over the past six months, it has soared 2.25%.

    Let’s see what’s going on with the company?

    CODX latest announcement

    On November 11, 2021, Co-Diagnostics, Inc. (CODX) released financial results for the third quarter ended September 30, 2021.

    Q3 2021 financial highlights

    • CODX reported total revenue of $30.1 million in Q3 2021 compared to $21.8 million in Q3 2020.
    • The cost of revenue was $3.3 million in Q3 2021 compared to $5.8 million in Q3 2020.
    • Gross profit increased 67.5% to $26.8 million in Q3 2021 compared to $16.0 million in Q3 2020.
    • Total operating expenses were $13.2 million compared to $4.0 million in Q3 2020.
    • It earned a net income of $11.5 million or $0.38per diluted share in Q3 2021 compared to a net income of $15.7 million or $0.53 per in the prior-year third quarter.
    • The company ended the quarter with cash, cash equivalents, and marketable securities of $83.9 million.

    FY 2021 Financial Outlook
    For FY 2021, Co-Diagnostics is expecting,

    • Total revenue to be in the range of $96.0 million to $100.0 million.
    • Diluted earnings per share are forecasted to be in the $1.07to $1.16

    Update about CODX Logix Smart™ COVID-19 2-Gene test

    On November 4, 2021, Co-Diagnostics, Inc. (CODX), announced that its Logix Smart™ SARS-CoV-2 2-Gene multiplex test has been validated according to the United Kingdom Health Security Agency’s (“UKHSA”) Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (CTDA) and is available for sale in the UK under the Regulation.

    India approve CODX Saragene™ test

    On October 6, 2021, Co-Diagnostics, Inc. (CODX) announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its Saragene™ Dengue and Chikungunya Multiplex RT-PCR test as an in vitro diagnostic (IVD).

    CODX At Home/Point of Care Device

    Co-Diagnostics, Inc. (CODX) introduced its upcoming at-home and point-of-care PCR device in a press conference at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, which was held on September 26-30 in Atlanta, GA. During the event, Co-Diagnostics also promoted its existing suite of diagnostics products and technology applications.

    Conclusion

    CODX stock performed well on Thursday, after its improved financial figures for Q3 2021. We can expect it to continue to remain in positive mode on Friday as well.

  • Everspin Technologies Inc. (MRAM) stock surged in the after-hours on Thursday, but Why?

    Everspin Technologies Inc. (MRAM) shares went up 21.58% in after-hours on Thursday, November 11, 2021, and closed daily trading at $8.00. However, in the regular trading session, MRAM’s stock lost 0.30%. MRAM shares have risen 8.76% over the last 12 months, and they have moved down 2.37% in the past week. Over the past three months, the stock has gained 14.43%, while over the past six months, it has gained 28.77%.

    Let’s have a brief look at its recent news and developments.

    MRAM latest development

    On November 11, 2021, Everspin Technologies, Inc. (MRAM), announced preliminary unaudited financial results for the third fiscal quarter of 2021.

    Q3 2021 financial highlights

    • MRAM reported total revenue of 14.8 million in Q3 2021 compared to $10.1 million of revenue in Q3 2020.
    • The total cost of revenue was $6.35 million in Q3 2021 compared to $7.8 million in Q3 2020.
    • In Q3 2021, the gross margin was 57.1%, compared to23.0% in the third quarter of 2020.
    • Total GAAP operating expenses were $4 million, compared to $6.04 million in Q3 2020.
    • It earned a net income of $880k or $0.05 per share for Q3 2021, compared to a net loss of $3.9 million or $0.21 per basic share for Q3 2020.
    • Adjusted EBITDA was $2.5 million in Q3 2021 compared to a negative $2.0 million in Q3 2020.
    • As of September 30, 2021, the company had cash and equivalents of $14.6 million.

    Q2 2021 financial results

    • In Q2, 2021, MRAM reported total revenue of $11.85 million compared to $11.83 million in Q2 2020.
    • The gross profit margin was 60.7%, compared to43.9% in the second quarter of 2020.
    • GAAP operating expenses for the second quarter of 2021 were $6.7 million compared to $6.3 million in Q2 2020.
    • It earned GAAP net income of $256k, or $0.01 per share in Q2 2021 compared to a net loss of $1.3 million, or $0.07 per share in Q2 2020.
    • Adjusted EBITDA was $1.5 million in Q2 2021 compared to $0.3 million in the second quarter of 2020.
    • The company ended the second quarter with cash and cash equivalents of $14.2 million, compared to $15.5 million at the end of the first quarter of 2021.

    Q4 2021 financial outlook

    • For the fourth quarter of 2021, Everspin expects total revenue in a range of $16.25 million to $17.25 million.
    • Everspin expects a GAAP net income per basic share of between $0.02 and $0.08 for Q4 2021.

    MRAM new appointment

    On September 03, 2021, Everspin Technologies, Inc. (MRAM), appointed Anuj Aggarwal as Chief Financial Officer of Everspin, effective immediately. Mr. Aggarwal had been serving as Interim Chief Financial Officer of Everspin since April 30, 2021.

    Conclusion

    The recent financial results took the MRAM stock to new heights and it can continue to perform well on Friday as well.

  • Why did Digital Brands Group Inc. (DBGI) stock turnaround in the after-hours on Thursday?

    Digital Brands Group Inc. (DBGI) shares rose 6.63% in after-hours on Thursday, November 11, 2021, and closed the daily trading at $4.18. However, in the regular trading session, DBGI’s stock lost 1.75%. The stock volume remained 1.26 million shares. DBGI shares have moved up 1.82% in the past week. Over the past three months, the stock has gained 26.45%, while over the past six months, it has gained 15.29%.

    Let’s discuss its recent news and developments.

    DBGI recent financial results

    On November 11, 2021, Digital Brands Group, Inc. (DBGI), announced its financial results for its third quarter ended September 30, 2021.

    Q3 2021 financial highlights

    • DBGI reported total revenue of $2.2 million in Q3 2021 compared to $1.2 million in Q3 2020.
    • The cost of revenue was $0.95 million in Q3 2021 compared to $1.73 million in Q3 2020.
    • Total operating expenses were $9.12 million in Q3 2021 compared to $2.9 million in Q3 2020.
    • The gross profit margin was55.9% inQ3 2021 compared to negative 40.1% in Q3 2020.
    • It suffered a net loss of $8.9 million, or $0.76 per diluted share in Q3 2021 compared to a net loss of $3.9 million, or $5.89 per diluted share, in the prior-year period.

    FY 2022 financial outlook

    • For FY 2022, the company is expecting net revenue in the range of $5 million to $42.5 million.
    • The company is expecting a positive EBITDA for 2022.

    DBGI new appointments

    On November 11, 2021, Digital Brands Group, Inc. (DBGI), announced that Lucy Doan has been elected to the Digital Brands Group, Inc. Board of Directors.

    Doan has 25 years of financial and strategic experience in the consumer industry. She currently serves on the Board of Directors of Grunt Style, an online apparel company.

    DBGI accepting cryptocurrencies payments

    On November 4, 2021, Digital Brands Group, Inc. (DBGI) start accepting cryptocurrencies as a form of payment across all its brands.

    The Chief Executive Officer of Digital Brands Group, Hil Davis said that Shopify enables our brands to accept cryptocurrencies as a form of payment. He further said that this form of payment will continue to grow as a potential currency in our industry.

    DBGI on Amazon

    On October 28, 2021, Digital Brands Group, Inc launched DSTLD on Amazon Prime, while it also launched its affiliate program across all its brands.

    DSTLD’s Brand Store will launch on Amazon with DSTLD’s videos and branded content. In addition to this, DBGI is also is launching an affiliate program across all its brands.

    Conclusion

    The recent financial results were the reason behind its turnaround and positive performance in the after-hours on Thursday. it can continue to perform well on Friday as well.

  • Here is why Blink Charging Co. (BLNK) stock performed well on Thursday?

    Blink Charging Co. (BLNK) shares surged 5.10% in after-hours on Thursday, November 11, 2021, and closed at $37.32. Even in the regular trading session, BLNK’s stock gained 8.16%. BLNK shares have risen 247.80% over the last 12 months, and they have moved up 11.04% in the past week. Over the past three months, the stock has gained 9.26%, while over the past six months, it has jumped 18.56%.

    Let’s have a look at its recent news and development.

    BLNK latest developments

    On November 11, 2021, Blink Charging Co. (BLNK) released its financial results for the third quarter ended September 30, 2021.

    Q3 2021 financial highlights

    • BLNK reported total revenue of $6.4 million in Q3 2021 compared to $0.9 million in Q3 2020.
    • The total cost of revenue was $5.5 million in Q3 2021 compared to $0.54 million in Q3 2020.
    • Total operating expenses were $16.7 million in Q3 2021 compared to $4.3 million in the same period in 2020.
    • It suffered a net loss of $15.3 million, or $0.36 per share in Q3 2021, compared to a net loss of $3.9 million, or $0.12 per share in the third quarter of 2020.
    • Adjusted EBITDA was negative $8.4 million in Q3 2021 compared to negative Adjusted EBITDA of $3.7 million in the prior-year period.
    • The company ended the quarter with $186.7 million of Cash and Marketable Securities.

    BLNK welcome the historic bipartisan infrastructure bill

    On November 08, 2021, Blink Charging Co. (BLNK, BLNKW) announced to support the historic bipartisan infrastructure bill and applauds the Biden Administration and congressional lawmakers who are taking an important step to improve our nation’s infrastructure and accelerating the adoption of electric vehicles.

    BLNK received grants from EGLE

    On November 03, 2021, Blink Charging Co. (BLNK, BLNKW) was awarded a grant from Michigan Consumers Energy and an additional grant from the Michigan Department of Environment, Great Lakes, and Energy (EGLE) for the installation of DC fast-charging stations across the state of Michigan. The six DC fast chargers were installed at two separate locations in Traverse City and Clare, Michigan.

    BLNK products update

    On October 07, 2021, Blink Charging Co. (BLNK, BLNKW) sold 64 Blink’s residential Level 2 residential charging stations, the HQ 150, to Rudy’s Performance Parts for resale across its distribution channels.

    BLNK Subsidiary Car Sharing Program

    On October 05, 2021, Blink Mobility which is a wholly-owned subsidiary of Blink Charging Co. (BLNK, BLNKW) expanded its BlueLA electric car-sharing program serving Los Angeles. Blink will add 300 street side EV charging stations at an anticipated 60 destinations across the city and a progressive increase in the Program’s electric vehicle fleet, based on utilization rates.

    Conclusion

    The BLNK stock performed well on Thursday after it announced its Q3 2021 results. We can see it continue its performance on Friday as well.

  • Here is why Moving iMage Technologies Inc. (MITQ) stock soared in the after-hours on Thursday?

    Moving iMage Technologies Inc. (MITQ) shares soared 21.48% in after-hours on Thursday, November 11, 2021, and closed the daily trading at $3.28. However, in the regular trading session, MITQ’s stock lost 0.37%. The stock volume remained 2.94 million shares. MITQ shares have moved down 2.53% in the past week. Over the past three months, the stock has lost 18.18%. The company has a current market of $29.30 million and its outstanding shares stood at 10.85 million.

    Let’s have a brief discussion about its recent developments

    MITQ latest announcement

    On November 11, 2021, Moving iMage Technologies, Inc. (MITQ), reported results for its first fiscal quarter ended September 30, 2021.

    Q1 2022 financial highlights

    • MITQ reported total revenue of $3.5 million in Q1 2022 compared to $1.8 million in Q1 2021.
    • The cost of revenue was $2.75 million in Q1 2022 compared to $1.30 million in Q1 2021.
    • Total operating expenses were $1.26 million in Q1 2022 compared to $760 million in Q1 2021.
    • It suffered a net loss of $0.6 million and a diluted loss per share of $0.06 in Q1 2022 compared to a net loss of $0.4 million and a diluted loss per share of $0.07 in Q1 2021.
    • As of September 30, 2021, the company had cash and cash equivalents of $11.0 million.

    MITQ upcoming event

    Moving iMage Technologies (MITQ) will be hosting a factory open house, including technology demonstrations on Thursday, January 20, 2022, following the International Cinema Technology Association (ICTA) Seminars in Los Angeles, CA January 17-19, 2022.

    The company will demonstrate MITs’ cutting-edge, new multi-language translator that enables outreach to an untapped customer base of non-native language proficient customers.

    Recognition for MITQ

    On October 21, 2021, Moving iMage Technologies won an award to provide equipment and furnishings for the new Alamo Crystal City location in Crystal City, VA.

    MITQ won a new contract

    On October 14, 2021, Moving iMage Technologies was awarded the contract from Alamo Drafthouse Cinema to provide equipment and furnishings for the new Alamo Drafthouse – City Foundry in St. Louis, MO.

    MITQ will provide, install and project manage all projection and sound equipment for a new ten-screen state-of-the-art cinema, which is currently scheduled to open in Summer 2022.

    MITQ participation in the recent event

    Moving iMage Technologies (MITQ) recently participated at the 14th annual LD Micro Main Event investor conference which was held on Thursday, October 14, 2021.

    The company was presented by co-founder and Executive Vice President, Sales and Marketing Joe Delgado during the event.

    MITQ paid its outstanding debt

    On October 06, 2021, Moving iMage Technologies (MITQ) paid its approximately $3.1 million debt by using existing cash on hand during the first quarter of fiscal 2022, eliminating substantially all short and long-term debt liabilities on the Company’s balance sheet. The Company’s remaining debt is a second Payroll Protection Program loan, which it expects to be entirely forgiven.

    Conclusion

    MITQ stock went up after the strong Q1 2022 financial results announcement. We can expect it to close the weekly trading in a positive mode as well.

  • Here is why Ampio Pharmaceuticals Inc. (AMPE) stock hit rock bottom on  Wednesday?

    Ampio Pharmaceuticals Inc. (AMPE) shares slumped 7.79% in after-hours on Wednesday, November 10, 2021, and closed the daily trading at $1.42. Even in the regular trading session, AMPE’s stock lost 5.52%. AMPE shares have risen 95.93% over the last 12 months, and they have moved down 7.23% in the past week. Over the past three months, the stock has gained 3.36%, while over the past six months, it has declined 15.38%.

    Let’s see what are the latest news about the company?

    AMPE latest news

    On November 10, 2021, Ampio Pharmaceuticals, Inc. (AMPE), announced results for the three- and nine-month periods ended September 30, 2021.

    Q3 2021 financial highlights

    • Total operating expenses were $3.85 million compared to $3.30 million in Q3 2020.
    • AMPE suffered a net loss of $3.63 million or a net loss of $0.02 per basic and diluted share in Q3 2021 compared to a net loss of $3.37 million or net loss of $0.02 per basic and diluted share in Q3 2020.
    • The company did not report any revenue or sales for Q3 2021.
    • As of September 30, 2021, the company had cash and cash equivalents totalling $17.1 million compared to $17.3 million on December 31, 2020.

    AMPE corporate changes

    On October 13, 2021, Ampio Pharmaceuticals (AMPE), appointed Howard Levy, M.B.B.Ch., PhD, M.M.M., as Chief Medical Officer (CMO) and J. Kevin Buchi and Michael Martino to the Ampio Pharmaceuticals Board of Directors.

    Dr Levy, Mr Buchi, and Mr Martino both have extensive experience as CEOs, senior executives, and board members of both private and public biopharmaceutical and pharmaceutical companies.

    The company also promoted Holli Cherevka to the position of President and Chief Operating Officer (COO).

    AMPE received DCGI approval for AP-019 Phase II study

    On September 21, 2021, the Drugs Controller General of India (DCGI) approved Ampio Pharmaceuticals (AMPE) Phase II AP-019 clinical trial in India. The study will utilize inhaled Ampion™ to treat those suffering from respiratory distress due to COVID-19.

    India has experienced over 33 million infections and over 440 thousand reported coronavirus-related deaths since the pandemic began.

    Ampion interrupts the hyperactive immune response associated with COVID-19 as an immunomodulatory agent with anti-inflammatory effects. The inhalation of Ampion allows the drug to directly target and attenuate inflammation in the lungs, caused by the Covid-19.

    Conclusion

    The recent financial results were the reason behind its negative performance on Wednesday. Still, the company is not generating and revenue and it reported a significant loss for Q3. We can expect it to further decline on Thursday as well.

  • Repro Med Systems Inc. (KRMD) stock surged on Wednesday after some important developments.

    Repro Med Systems Inc. (KRMD) shares went up 14.54% in after-hours on Wednesday, November 10, 2021, and closed at $3.23. Even in the regular trading session, KRMD’s stock gained 0.71%. KRMD shares have fallen 26.37% over the last 12 months, and they have moved down 12.96% in the past week. Over the past three months, the stock has lost 19.20%, while over the past six months, it has declined 32.37%.

    Let’s have a brief look at its recent news and developments.

    KRMD received FDA clearance for prefilled syringes (Hizentra)

    On November 10, 2021, Repro Med Systems, Inc. (KRMD) received FDA clearance for use of the KORU Medical FreedomEdge infusion pump to deliver Hizentra® [immune globulin subcutaneous (human) 20% liquid] 20 mL prefilled syringes. Hizentra® is the most prescribed subcutaneous Ig product and the first to be available in a prefilled syringe format.

    KRMD latest financial results

    On November 10, 2021, Repro Med Systems, Inc. (KRMD) reported financial results for the third quarter that ended September 30, 2021.

    Q3 2021 financial highlights

    • KRMD reported total revenue of $6.0 million in Q3 2021 compared to $6.1 million in Q3 2020.
    • In Q3 2021, the gross margin was 57.9% compared to 64.8% in Q3 2020.
    • Total operating expenses for the third quarter of 2021 were $4.8 million, compared to $3.6 million for the same period in 2020.
    • It suffered a net loss of $1.1 million, or $0.02 per diluted share in Q3 2021, compared with net income of $0.2 million, or $0.01 per diluted share in Q3 2020.

    KRMD participation in the upcoming events

    Repro Med Systems, Inc. (KRMD) will participate at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum which is to be held on Thursday, November 18, 2021, at 11:00 AM EST.

    The company will also participate in the 33rd Annual Piper Sandler Healthcare Conference which will take place Wednesday, December 1, 2021.

    KRMD collaboration with Gilero

    On November 08, 2021, Repro Med Systems, Inc (KRMD) announced its collaboration with Gilero. Gilero offers unparalleled engineering and manufacturing solutions and has been a trusted partner for medical and drug delivery device companies for 20 years.

    KRMD new appointments

    On November 01, 2021, Repro Med Systems, Inc. (KRMD) appointed two new leaders who will be responsible for key elements of the Company’s growth strategy.

    Rob Cannon was appointed as the Company’s new Vice President of Sales and he will be responsible for U.S. sales and increasing the overall penetration of subcutaneous therapy for commercialized biopharmaceutical drugs. Brian Hertzog was appointed as the Company’s new Vice President of BioPharma Business Development and he will be responsible for leading biopharmaceutical business development and increasing the number of new biopharmaceutical drugs on the Freedom platform.

    Conclusion

    The latest financial results announcement and FDA approval for prefilled syringes were the reason behind its good performance on Wednesday and it can continue its momentum on Thursday as well.

  • Why iFresh Inc. (IFMK) could not hold on to its early gains in the after-hours on Wednesday?

    iFresh Inc. (IFMK) shares plunged 10.17% in after-hours on Thursday, November 10, 2021, and closed the daily trading at $1.06. However, in the regular trading session, IFMK’s stock gained 36.45%. IFMK shares have risen 55.73% over the last 12 months, and they have moved up 34.09% in the past week. Over the past three months, the stock has lost 6.35%, while over the past six months, it has declined 9.92%.

    Let’s see is there any reason behind its turnaround towards negativity in the after-hours on Wednesday?

    IFMK partnership with Tmall Global

    On November 10, 2021, iFresh, Inc. (IFMK), entered into a Master Product Supply Agreement with Alibaba.com Singapore E-Commerce Private Limited (Tmall Global). This Agreement establishes a cross-border trade partnership, enabling iFresh to sell American food and products to China via Tmall Global’s cross-border e-commerce platform.

    According to the agreement, iFresh will bring fresh, high-quality American food and products to Tmall Global, including products like infant formula, dried fruit, coffee, and other snacks. Tmall Global will provide one-stop control and the management service of sorting, packaging, and distribution. Services will be carried out directly from the overseas warehouse to the end-consumers in China, all on time.

    IFMK response to Nasdaq notice

    On September 22, 2021, Nasdaq notified iFresh (IMFK) that due to the Company’s continued non-compliance with Nasdaq’s annual meeting and filing requirements, as outlined in Nasdaq Listing Rules 5620(a) and 5250(c)(1), respectively, the Company’s securities were subject to delisting unless the Company timely requests a hearing before a Nasdaq Hearings Panel.

    The Company timely requested a hearing before the Panel, Concurrent with the hearing request and as allowed by the Nasdaq Listing Rules, the Company also requested a further stay of Nasdaq’s determination.

    IFMK agreement with Bit Farm

    On August 30, 2021, iFresh, Inc. (IFMK) entered into an exclusive agency agreement with Bit Farm Inc. This agreement will make iFresh the exclusive distributor of Bit Silica +, which is a fertilizer that promotes plant growth. iFresh is authorized to market and sell Bit Silica Plus in the United States for the next twelve months, with an option to extend.

    Strong 2021 Harvest and Sales of Exotic Fruit products

    On August 02, 2021, iFresh, Inc. (IFMK), reported that its sales of dragon fruit, lychee, and longan this year have been strong. The increase in sales is due to a bountiful harvest from Dragon Seeds, a 15-acre farm based in Vero Beach, FL.

    Conclusion

    Well, we have a reason for its exceptional early surged on Wednesday but there was no reason for its decline in the after-hours session. We can expect it to return towards positivity in the coming trading session on Thursday.

  • Here is why Root Inc. (ROOT) Stock performed well in the after-hours on Wednesday?

    Root Inc. (ROOT) shares rose 13.70% in after-hours on Wednesday, November 10, 2021, and closed the daily trading at $5.31. However, in the regular trading session, ROOT’s stock lost 5.66%. ROOT shares have fallen 79.60% over the last 12 months, and they have moved down 8.07% in the past week. Over the past three months, the stock has lost 15.70%, while over the past six months, it has declined 48.05%.

    Let’s have a look at its recent developments.

    ROOT latest financial results

    On November 10, 2021, Root, Inc announced financial results for the quarter that ended September 30, 2021.

    Q3 2021 financial highlights

    • ROOT reported total revenue of $93.8 million in Q3 2021 compared to $50.5 million in Q3 2020.
    • Total operating expenses were $220.7 million for the third quarter of 2021 compared to $116.2 million in Q3 2020.
    • It suffered a net loss of $133 million or $0.53 loss per basic and diluted share in Q3 2021 compared to a net loss of $85.2 million or $2.20 loss per basic and diluted share in Q3 2020.

    ROOT important organizational change

    On September 20, 2021, Root, Inc. appointed Daniel Rosenthal as the company’s first Chief Revenue and Operating Officer.

    Rosenthal will have responsibility for functions aimed at driving revenue and streamlining operations within the business. In this new role, Dan will oversee performance marketing and growth, corporate strategy, business development, and insurance, including underwriting and pricing initiatives.

    ROOT Drop the Score Campaign

    On September 16, 2021, Root, Inc celebrated the first anniversary of its Drop the Score campaign to eliminate credit discrimination from auto insurance. The campaign’s anniversary comes as the National Association of Insurance Commissioners (NAIC), a regulatory body that includes commissioners from all 50 states, launches an investigation into industry practices.

    ROOT Q2 2021 financial results announcement

    On August 11, 2021, Root, Inc. announced financial results for the quarter that ended June 30, 2021.

    • Revenue was $89.8 million in Q2 2021 compared to $121.4 million in Q2 2020.
    • Total operating expenses were $261.9 million compared to $152.6 million in Q2 2020.
    • It suffered a net loss of $178.6 million in Q2 2021 compared to a net loss of $38.9 million in Q2 2020.

    Conclusion

    Well, Q3 2021 results are not so impressive but it tops the revenue estimates due to which it surged in the after-hours session on Wednesday. we can see it to surge more on Thursday as well.

  • Why did The Original BARK Company (BARK) stock turn around in the after-hours on Wednesday, after the early loss?

    The Original BARK Company (BARK) shares surged 5.97% in after-hours on Wednesday, November 10, 2021, and closed the daily trading at $7.45. However, in the regular trading session, BARK’s stock lost 6.02%. BARK shares have moved down 2.36% in the past week. Over the past three months, the stock has lost 22.66%, while over the past six months, it has declined 29.13%.

    Let’s see what’s happening in the company recently?

    BARK latest news

    On November 10, 2021, The Original BARK Company released its financial results for the fiscal second quarter ended September 30, 2021.

    Q2 2022 financial highlights

    • BARK reported revenue of $120.2 million in the second quarter of the fiscal year 2022 compared to $86.4 million in the second quarter of the fiscal year 2021.
    • In Q2 2022, the gross profit was $69.9 million compared to $51.6 million in the second quarter of the fiscal year 2021.
    • Total operating expenses were $85.3 million in Q2 2022 compared to $52.4 million in Q2 2021.
    • It reported a net income of $6.5 million in Q2 2022 compared to a net loss of $1.4 million in Q2 2022.
    • Adjusted EBITDA was $8.8 million in Q2 2022 compared to $1.1 million in Q2 2021.
    • The company ended the quarter with a cash and cash equivalents balance of $272.6 million.

    Q3 2022 financial guidance

    • The Company expects total revenue in the range of $137 to $139 million.

    FY 2022 financial outlook

    • Due to uncertainty, for the fiscal year 2022, the Company anticipates roughly 2% of the risk to the $516 million of revenue guidance originally provided in December of 2020.
    • Adjusted EBITDA is expected in the range of $38 million to $40 million.

    BARK corporate updates

    On October 14, 2021The Original BARK Company expanded its leadership team to advance the Company’s long-term strategic growth plans.

    • Michael Novotny was appointed as President of BARK Eats. He has been serving as Chief Operating Officer of BARK since 2019.
    • Anil Nair was appointed as Chief Supply Chain Officer. He has 15 years of work experience and recently he worked as Director at Global Logistics at Amazon.
    • Olly Downs joined BARK as Vice President of Data, Analytics, and Machine Learning, with 20 years of work experience, and 41 U.S. patents. Before joining BARK, he served as Vice President, Marketing Technology, Data & Machine Learning at e-commerce retailer Zulily.

    BARK CFO transition

    On September 16, 2021, the CFO of The Original BARK Company, John Toth resigned from his position to spend more time with his family on the West Coast. BARK has retained an executive search firm to assist the Company’s board of directors with identifying a new Chief Financial Officer. John will continue in his role to ensure a smooth and constructive transition to his successor.

    Conclusion

    The recent financial results were the reason behind its positive performance in the after-markets on Tuesday and it approximately recovered its early loss. Let’s see how it commences trading on Thursday?